Full name
FUNKBIOTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
FUNKBIOTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ALEJA WARSZAWSKA 163, 20-824 LUBLIN
TAX ID7123420677
Rate company:
FUNKBIOTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7123420677
KRS0000908061
Share capital5,000.00 zł
address
UL. ALEJA WARSZAWSKA 163, 20-824 LUBLIN
Website
www.funkbiotics.comCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7123420677
REGON
389263991
KRS
0000908061
Legal form
limited liability company
Register Address
UL. ALEJA WARSZAWSKA 163, 20-824 LUBLIN
Date of registration in KRS
2021-06-23
Date of commencement of economic activity
2021-06-23
Act signature
LU.VI NS-REJ.KRS/15867/23/914/ADE
Website
WWW.FUNKBIOTICS.COM
Pkd codes
72.19.Z - Scientific research and development activities
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
72.11.Z - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL68 1140 2004 0000 3902 8244 8924 
PL03 1140 2004 0000 3402 8145 9581 EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -4,3 | -61,3 | -31,6 | 48,5 |
EBITDA | -4,3 | -61,3 | -31,6 | 48,5 |
Short time liabilities | 6,2 | 146,6 | 230,4 | 57,2 |
Equity capital | 0,7 | -60,6 | -92,2 | -52,1 |
Operating profit (EBIT) | -4,3 | -61,3 | -31,6 | 48,5 |
Assets | 6,8 | 384,9 | 831,5 | 116,1 |
Net profit (loss) | -4,3 | -61,3 | -31,6 | 48,5 |
Cash | 6,8 | 34,3 | 3,3 | -90,4 |
Liabilities and provisions for liabilities | 6,2 | 445,5 | 923,8 | 107,3 |
Net income from sale | 0 | 2,8 | 5,8 | 106,3 |
Working assets | 6,8 | 37,4 | 19,3 | -48,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -619,4 | 101,1 | 34,2 | -66,9 |
Equity capital to total assets | 10,2 | -15,8 | -11,1 | 4,7 |
Gross profit margin | -2190,9 | -546,9 | 1644 | |
EBITDA Margin | -2190,9 | -546,9 | 1644 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 19 110 | 14 558 | -4552 |
Current financial liquidity indicator | 1.1130081415176392 | 0.08398318290710449 | 0.020920105278491974 | -0,1 |
Net dept to EBITDA | 0.1614401787519455 | -1.4850192070007324 | -7.184270858764648 | -5,7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
LM Line sp. z o.o.
Szczecin
HAMED Hurtownia sprzętu medycznego
Warszawa
Red Med Poland Sp. z o.o.
Chorzów
Gama Sp. z o.o.
Ruda Śląska
Bioevolution sp. z o.o. sp.k.
Warszawa
Gedeon Richter Polska sp. z o.o.
Grodzisk Mazowiecki
CMS Polska sp. z o.o.
Rzeszów